Guided Therapeutics (GTHP) Stock Chart & Stock Price History $0.28 0.00 (0.00%) As of 09/5/2025 02:10 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Guided Therapeutics Stock Price Performance The Guided Therapeutics (GTHP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 111.32%, with a year-to-date return of 86.67%. In the past month, the stock has increased 64.51%, reflecting recent market activity. As of the latest close, Guided Therapeutics traded at $0.28 with a market cap of $23.24 million and volume of 1,360 shares. Receive GTHP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+0.18%1 Month Performance+64.51%3 Month Performance+68.07%Year-To-Date Performance+86.67%1 Year Performance+111.32% GTHP Stock Chart for Sunday, September, 7, 2025 GTHP Chart by TradingView Guided Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/05/2025$0.28$0.28$0.28$0.241,360 shs$23.24 million09/04/2025$0.26$0.28+8.53%$0.28$0.25723 shs$23.24 million09/03/2025$0.28$0.26-7.69%$0.26$0.261,101 shs$21.41 million09/02/2025$0.28$0.28$0.28$0.243,245 shs$23.20 million09/01/2025$0.28$0.28$0.28$0.243,245 shs$23.20 million08/29/2025$0.27$0.28+3.52%$0.28$0.243,245 shs$22.44 million08/28/2025$0.28$0.27-3.57%$0.28$0.2413,898 shs$21.68 million08/27/2025$0.28$0.28$0.28$0.281,251 shs$22.48 million08/26/2025$0.26$0.28+8.11%$0.29$0.2394,372 shs$22.48 million08/25/2025$0.26$0.26-1.48%$0.26$0.261,214 shs$20.79 million Get the Latest News and Ratings for GTHP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/22/2025$0.27$0.26-1.17%$0.28$0.222,068 shs$21.11 million08/21/2025$0.30$0.27-9.83%$0.29$0.279,087 shs$21.35 million08/20/2025$0.23$0.30+29.96%$0.30$0.231,303 shs$23.68 million08/19/2025$0.26$0.23-13.69%$0.26$0.234,495 shs$18.22 million08/18/2025$0.28$0.26-4.36%$0.30$0.2365,411 shs$21.11 million08/15/2025$0.25$0.28+8.35%$0.28$0.214,739 shs$22.08 million08/14/2025$0.20$0.25+30.15%$0.25$0.1736,492 shs$20.38 million08/13/2025$0.20$0.20$0.20$0.1616,130 shs$15.66 million08/12/2025$0.20$0.20$0.20$0.153,296 shs$15.66 million08/11/2025$0.14$0.20+38.20%$0.20$0.122,620 shs$15.66 million08/08/2025$0.17$0.14-17.10%$0.20$0.121,252 shs$11.33 million08/07/2025$0.21$0.17-18.95%$0.24$0.1755,149 shs$13.66 million08/06/2025$0.24$0.21-12.50%$0.24$0.218,063 shs$16.86 million Related Companies Baird Medical Investment Stock Chart EDAP TMS Stock Chart Apyx Medical Stock Chart Nutriband Stock Chart TELA Bio Stock Chart Pulmonx Stock Chart QT Imaging Stock Chart Vivani Medical Stock Chart IceCure Medical Stock Chart Cytosorbents Stock Chart Receive GTHP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:GTHP) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guided Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
